BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

544 related articles for article (PubMed ID: 21222284)

  • 1. Sumoylation as a signal for polyubiquitylation and proteasomal degradation.
    Miteva M; Keusekotten K; Hofmann K; Praefcke GJ; Dohmen RJ
    Subcell Biochem; 2010; 54():195-214. PubMed ID: 21222284
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Reconstitution of SUMO-dependent ubiquitylation in vitro.
    Keusekotten K; Praefcke GJ
    Methods Mol Biol; 2012; 832():111-23. PubMed ID: 22350879
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Necdin promotes ubiquitin-dependent degradation of PIAS1 SUMO E3 ligase.
    Gur I; Fujiwara K; Hasegawa K; Yoshikawa K
    PLoS One; 2014; 9(6):e99503. PubMed ID: 24911587
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Methods to study SUMO dynamics in yeast.
    Pabst S; Döring LM; Petreska N; Dohmen RJ
    Methods Enzymol; 2019; 618():187-210. PubMed ID: 30850052
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Arkadia/RNF111 is a SUMO-targeted ubiquitin ligase with preference for substrates marked with SUMO1-capped SUMO2/3 chain.
    Sriramachandran AM; Meyer-Teschendorf K; Pabst S; Ulrich HD; Gehring NH; Hofmann K; Praefcke GJK; Dohmen RJ
    Nat Commun; 2019 Aug; 10(1):3678. PubMed ID: 31417085
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The adenovirus E4-ORF3 protein functions as a SUMO E3 ligase for TIF-1γ sumoylation and poly-SUMO chain elongation.
    Sohn SY; Hearing P
    Proc Natl Acad Sci U S A; 2016 Jun; 113(24):6725-30. PubMed ID: 27247387
    [TBL] [Abstract][Full Text] [Related]  

  • 7. UHRF2, a ubiquitin E3 ligase, acts as a small ubiquitin-like modifier E3 ligase for zinc finger protein 131.
    Oh Y; Chung KC
    J Biol Chem; 2013 Mar; 288(13):9102-11. PubMed ID: 23404503
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Cystic fibrosis transmembrane conductance regulator degradation: cross-talk between the ubiquitylation and SUMOylation pathways.
    Ahner A; Gong X; Frizzell RA
    FEBS J; 2013 Sep; 280(18):4430-8. PubMed ID: 23809253
    [TBL] [Abstract][Full Text] [Related]  

  • 9. c-Myc is targeted to the proteasome for degradation in a SUMOylation-dependent manner, regulated by PIAS1, SENP7 and RNF4.
    González-Prieto R; Cuijpers SA; Kumar R; Hendriks IA; Vertegaal AC
    Cell Cycle; 2015; 14(12):1859-72. PubMed ID: 25895136
    [TBL] [Abstract][Full Text] [Related]  

  • 10. SUMO-targeted ubiquitin ligases.
    Sriramachandran AM; Dohmen RJ
    Biochim Biophys Acta; 2014 Jan; 1843(1):75-85. PubMed ID: 24018209
    [TBL] [Abstract][Full Text] [Related]  

  • 11. The Molecular Interface Between the SUMO and Ubiquitin Systems.
    Staudinger JL
    Adv Exp Med Biol; 2017; 963():99-110. PubMed ID: 28197908
    [TBL] [Abstract][Full Text] [Related]  

  • 12. RNF4 is a poly-SUMO-specific E3 ubiquitin ligase required for arsenic-induced PML degradation.
    Tatham MH; Geoffroy MC; Shen L; Plechanovova A; Hattersley N; Jaffray EG; Palvimo JJ; Hay RT
    Nat Cell Biol; 2008 May; 10(5):538-46. PubMed ID: 18408734
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Methods to analyze STUbL activity.
    Branigan E; Plechanovová A; Hay RT
    Methods Enzymol; 2019; 618():257-280. PubMed ID: 30850055
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Crosstalk between the SUMO and ubiquitin pathways.
    Hunter T; Sun H
    Ernst Schering Found Symp Proc; 2008; (1):1-16. PubMed ID: 19202597
    [TBL] [Abstract][Full Text] [Related]  

  • 15. SIM-dependent enhancement of substrate-specific SUMOylation by a ubiquitin ligase in vitro.
    Parker JL; Ulrich HD
    Biochem J; 2014 Feb; 457(3):435-40. PubMed ID: 24224485
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Ubiquitin-dependent proteolytic control of SUMO conjugates.
    Uzunova K; Göttsche K; Miteva M; Weisshaar SR; Glanemann C; Schnellhardt M; Niessen M; Scheel H; Hofmann K; Johnson ES; Praefcke GJ; Dohmen RJ
    J Biol Chem; 2007 Nov; 282(47):34167-75. PubMed ID: 17728242
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Analysis of cellular SUMO and SUMO-ubiquitin hybrid conjugates.
    Schnellhardt M; Uzunova K; Bade VN; Krause A; Weisshaar SR; Praefcke GJ; Dohmen RJ
    Methods Mol Biol; 2012; 832():81-92. PubMed ID: 22350877
    [TBL] [Abstract][Full Text] [Related]  

  • 18. SUMO-SIM interactions: From structure to biological functions.
    Lascorz J; Codina-Fabra J; Reverter D; Torres-Rosell J
    Semin Cell Dev Biol; 2022 Dec; 132():193-202. PubMed ID: 34840078
    [TBL] [Abstract][Full Text] [Related]  

  • 19. SUMO conjugation - a mechanistic view.
    Pichler A; Fatouros C; Lee H; Eisenhardt N
    Biomol Concepts; 2017 Mar; 8(1):13-36. PubMed ID: 28284030
    [TBL] [Abstract][Full Text] [Related]  

  • 20. In Vitro SUMOylation Assay to Study SUMO E3 Ligase Activity.
    Yang WS; Campbell M; Kung HJ; Chang PC
    J Vis Exp; 2018 Jan; (131):. PubMed ID: 29443041
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 28.